BRAF antibody
Quick Overview for BRAF antibody (ABIN7598850)
Target
See all BRAF AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Purpose
- Anti-Braf
-
Specificity
- Braf
-
Immunogen
- Peptide derived from human B-raf surrounding the Val-600 residue (corresponds to Val 637 of mouse or rat B-raf)
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 20 mM Tris-HCI, pH 8.0, Stabilizer: 20 mg/mL BSA, Preservative: 0.05 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C
-
Storage Comment
- +2 °C to +8 °C
-
-
- BRAF (B-Raf proto-oncogene, serine/threonine kinase (BRAF))
-
Alternative Name
- Braf
-
Background
- B-raf proto-oncogene belongs to a large group of serine/threonine kinases of RAF family, involved in the transduction of mitogenic signals from the cell membrane to the nucleus. This protein kinase is frequently mutated in thyroid cancer and human melanomas, less frequently in other types of malignant tissues, including colorectal cancers, lung cancers and gliomas. Ninety percent of B-raf mutations are represented by B-raf V600-E mutation, presented by up to 500-fold increased activation in MEK/ERK signaling in tumor cells.
-
UniProt
- P15056
-
Pathways
- MAPK Signaling, RTK Signaling, Neurotrophin Signaling Pathway, Ribonucleoprotein Complex Subunit Organization, Hepatitis C, Autophagy
Target
-